These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6993193)

  • 1. Effect of acetylcholine on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in pancreatectomized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):33-8. PubMed ID: 6993193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hypophysectomy and hypophysis-transplantation on the secretion of gut glucagon immunoreactivity and gut glucagon-like immunoreactivity in depancreatized dogs.
    Yoshida T; Kondo M
    Endocrinol Jpn; 1980 Feb; 27(1):77-81. PubMed ID: 6248336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs.
    Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Failure of somatostatin to decrease blood glucose by suppression of extrapancreatic glucagon in severely diabetic depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Tarui S
    Endocrinol Jpn; 1978 Dec; 25(6):529-32. PubMed ID: 751798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half life of gastrointestinal glucagon-like immunoreactive materials.
    Tanaka R; Matsuyama T; Shima K; Sawazaki N; Tarui S; Kumahara Y
    Endocrinol Jpn; 1979 Feb; 26(1):59-63. PubMed ID: 436801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of response of gut GLI to fat ingestion in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in blood glucose and release of gut glucagon-like immunoreactive materials by bombesin infusion in the dog.
    Matsuyama T; Namba M; Nonaka K; Tarui S; Tanaka R; Shima K
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():115-9. PubMed ID: 7014201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose.
    Unger RH; Ohneda A; Valverde I; Eisentraut AM; Exton J
    J Clin Invest; 1968 Jan; 47(1):48-65. PubMed ID: 5638120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs.
    Mashiter K; Harding PE; Chou M; Mashiter GD; Stout J; Diamond D; Field JB
    Endocrinology; 1975 Mar; 96(3):678-93. PubMed ID: 1116479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs.
    Matsuyama T; Tanaka R; Shima K; Nonaka K; Tarui S
    Diabetologia; 1978 Dec; 15(6):471-4. PubMed ID: 720780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gastric glucagon immunoreactivity in pancreatectomized dogs.
    Ikei S; Mori K; Sakamoto Y; Ishii J; Watanabe O; Inoue M; Akagi M
    Jpn J Surg; 1980 Sep; 10(3):255-60. PubMed ID: 7012409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma glucagon-like immunoreactivity (GLI) in dogs.
    Oneda A; Horigome K; Yanbe A; Ishii S; Itabashi H
    Tohoku J Exp Med; 1975 Apr; 115(4):337-43. PubMed ID: 1145615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal metabolism of gut glucagon-like immunoreactivity.
    Rovira A; López-Novoa JM; Zubiaur M; Matesanz R; Ghiglione M; Pascual JM; Valverde I
    Endocrinology; 1982 Jun; 110(6):2030-6. PubMed ID: 6896180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response of extrapancreatic glucagon to gastrointestinal hormones in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Tohoku J Exp Med; 1985 Aug; 146(4):439-47. PubMed ID: 3907014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for transformation of glucagon-like immunoreactivity of gut into pancreatic glucagon in vivo.
    Korányi L; Péterfy F; Szabó J; Török A; Guóth M; Tamás G
    Diabetes; 1981 Sep; 30(9):792-4. PubMed ID: 6114889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of intraluminal bile or bile acids on release of gut glucagon-like immunoreactive materials in the dog.
    Namba M; Matsuyama T; Nonaka K; Tarui S
    Horm Metab Res; 1983; 15(2):82-4. PubMed ID: 6826142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.